ADC Therapeutics SA (ADCT)

ADC Therapeutics Market Cap

ADC Therapeutics has a market cap or net worth of $401.74 million as of May 17, 2024. Its market cap has increased by 106.34% in one year.

• Market Cap: 401.74M
• Enterprise Value: 290.35M
• 1-Year Change: 106.34%
• Ranking: #3151
• Category: Small-Cap
• Stock Price: $4.10

Market Cap Chart

Since May 15, 2020, ADC Therapeutics's market cap has decreased from $1.98B to $401.74M, a decrease of -79.74%. That is a compound annual growth rate of -32.85%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	339.50M	0.24%
May 16, 2024	338.70M	-0.96%
May 15, 2024	342.00M	2.21%
May 14, 2024	334.60M	-3.57%
May 13, 2024	347.00M	-2.56%
May 10, 2024	356.10M	-5.92%
May 9, 2024	378.50M	3.64%
May 8, 2024	365.20M	-8.70%
May 7, 2024	400.00M	8.55%
May 6, 2024	368.50M	-8.88%
May 3, 2024	404.40M	3.59%
May 2, 2024	390.40M	0.44%
May 1, 2024	388.70M	6.79%
Apr 30, 2024	364.00M	-1.99%
Apr 29, 2024	371.40M	3.69%
Apr 26, 2024	358.20M	-2.24%
Apr 25, 2024	366.40M	-7.12%
Apr 24, 2024	394.50M	-3.83%
Apr 23, 2024	410.20M	6.21%
Apr 22, 2024	386.20M	-0.85%
Apr 19, 2024	389.50M	-0.84%
Apr 18, 2024	392.80M	-4.03%
Apr 17, 2024	409.30M	11.71%
Apr 16, 2024	366.40M	1.58%
Apr 15, 2024	360.70M	-0.44%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
LENZ Therapeutics	416.71M
Nevro	416.32M
Enhabit	413.38M
Health Catalyst	410.29M
Bioventus	408.50M
Esperion Therapeutics	399.63M
Annexon	396.47M
Replimune Group	394.11M